Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea, page-24

Yeah, sounds like the doggie trial was badly run with too many dogs not meeting the specific inclusion criteria (whatever that was). i.e. dogs that were not eligible or unlikely to benefit were allowed into the trial. Whatever the reason I'm glad the results will be overshadowed by the much more important 1702 news.
Also, from memory I think the doggie trial was just using a more concentrated version of the cream to see if that gave better results. If so, we've already learnt that from this 1702 data. Basically more is not better and potentially causes more issues. 10% works well, and there is no point in making it 20% as the results are not as good. I like the fact that every visit showed increased results, hopefully they'll have some people carrying on with the treatment and seeing if they just keep getting better and better. Looking forward to the Zoom chat soon.